What is CaNCURE?

CaNCURE was created to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Over 50 trainees have already completed the program.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research lab.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
 Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

66

Trainees

33

Mentors

22

Publications

108

Presentations


Hear from our Alumni:

“I have been able to work on a project focused on studying novel cell lines generated from patient with rare undifferentiated sarcomas in children, but also have had the opportunity to shadow in the clinic on a couple of occasions. This experience has awoken the idea of possibly pursing a career as a physician scientist and/or many other options that I had not considered in the past as career choices.”

Bryan Kynnap, Health Sciences, ’16


Trainee Spotlight


Mostafa Abdelhalim

Biochemistry, '21

Targeted Delivery of Liposomes using PARP Inhibitors to Treat Non-Small Cell Lung Cancer

Vivian Zhang

Chemical Eng / Biochemistry, '21

Creating Animal Models of High-grade Serous Ovarian Cancer Cells

Nidhi Shankar

Health Science, '19

Molecular Analysis of Plasma Vesicles for Early Pancreatic Cancer Detection

Featured Trainee Publication


Upcoming Events

Recent Advances in the Knowledge Base of Nanotoxicology: Pulmonary Responses to Carbon Nanotubes

Tuesday, February 19, 2019

Vincent Castranova, PhD Department of Pharmaceutical Sciences, West Virginia University

119 Snell Libary -- NEU, 3:25 PM


Mentor Spotlight


Anna Moore, Ph.D.

Professor of Radiology, HMS

Our research deals with non-invasive imaging of molecular targets in cancer. Students with have the opportunity to explore the use of targeted multimodal nanoparticles for imaging of tumor growth, metastasis, and treatment.


Annick D. van den Abbeele, M.D.

Chief of Radiology, DFCI

A major goal of our research laboratory is to use anatomic & functional imaging in pre-clinical and clinical settings as a noninvasive whole-body tool to evaluate novel cancer therapies. Students will participate in the study design, image analysis and interpretation of pre-clinical and patient data that support the development of novel therapies in cancer.


Trainee Spotlight


Daem Celestin

Cell and Molecular Biology, '21

The Nano-plasmonic Exosome (nPLEX) Assay for Pancreatic Ductal Adenocarcinoma Diagnosis and Prognosis

Mostafa Abdelhalim

Biochemistry, '21

Targeted Delivery of Liposomes using PARP Inhibitors to Treat Non-Small Cell Lung Cancer

Rreze Grajcevci

Health Sciences, '21

Analyzing metastasis through targeted miRNA nanotherapy in aggressive breast cancer


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...